<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=AR-R17779</id>
	<title>AR-R17779 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=AR-R17779"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=AR-R17779&amp;action=history"/>
	<updated>2026-06-25T07:26:23Z</updated>
	<subtitle>在这个wiki上该页的修订历史</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=AR-R17779&amp;diff=4139921&amp;oldid=prev</id>
		<title>imported&gt;Nucleus hydro elemon：​使用HotCat已添加Category:烟碱激动剂</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=AR-R17779&amp;diff=4139921&amp;oldid=prev"/>
		<updated>2024-02-19T00:26:54Z</updated>

		<summary type="html">&lt;p&gt;使用&lt;a href=&quot;/index.php?title=WP:HOTCAT&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HOTCAT（页面不存在）&quot;&gt;HotCat&lt;/a&gt;已添加&lt;a href=&quot;/wiki/Category:%E7%83%9F%E7%A2%B1%E6%BF%80%E5%8A%A8%E5%89%82&quot; title=&quot;Category:烟碱激动剂&quot;&gt;Category:烟碱激动剂&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Chembox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| verifiedrevid = 477236447&lt;br /&gt;
| Name = &lt;br /&gt;
| ImageFile = AR-R17779 Structure.svg&lt;br /&gt;
| ImageSize = 150px&lt;br /&gt;
| ImageFile2 = AR-R17779 molecule ball.png&lt;br /&gt;
| IUPACName = (2&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-4′-Azaspiro[bicyclo[2.2.2]octane-2,5′-[1,3]oxazolidin]-2′-one&lt;br /&gt;
| OtherNames = (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one]&lt;br /&gt;
|Section1={{Chembox Identifiers&lt;br /&gt;
| Abbreviations = &lt;br /&gt;
| InChI = 1/C9H14N2O2/c12-8-10-5-9(13-8)6-11-3-1-7(9)2-4-11/h7H,1-6H2,(H,10,12)/t9-/m0/s1&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|correct|EBI}}&lt;br /&gt;
| ChEMBL = 193016&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}&lt;br /&gt;
| StdInChIKey = TYAGAVRSOFABFO-VIFPVBQEBZ&lt;br /&gt;
| CASNo_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CASNo = 178419-47-1&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = C3VZ57BN3M&lt;br /&gt;
| EINECS = &lt;br /&gt;
| PubChem = 5310971&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 4470515&lt;br /&gt;
| SMILES = O=C3O[C@]1(CN2CCC1CC2)CN3&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C9H14N2O2/c12-8-10-5-9(13-8)6-11-3-1-7(9)2-4-11/h7H,1-6H2,(H,10,12)/t9-/m0/s1&lt;br /&gt;
| RTECS = &lt;br /&gt;
| MeSHName = &lt;br /&gt;
| ChEBI_Ref = {{ebicite|changed|EBI}}&lt;br /&gt;
| ChEBI = CHEBI:420311&lt;br /&gt;
| KEGG_Ref = {{keggcite|correct|kegg}}&lt;br /&gt;
| KEGG = &lt;br /&gt;
}}&lt;br /&gt;
|Section2={{Chembox Properties&lt;br /&gt;
| C=9 | H=14 | N=2 | O=2&lt;br /&gt;
| Appearance = &lt;br /&gt;
| Density = &lt;br /&gt;
| MeltingPt = &lt;br /&gt;
| MeltingPt_notes = &lt;br /&gt;
| BoilingPt = &lt;br /&gt;
| BoilingPt_notes = &lt;br /&gt;
| Solubility = &lt;br /&gt;
| SolubleOther = &lt;br /&gt;
| Solvent = &lt;br /&gt;
| LogP = &lt;br /&gt;
| VaporPressure = &lt;br /&gt;
| HenryConstant = &lt;br /&gt;
| AtmosphericOHRateConstant = &lt;br /&gt;
| pKa = &lt;br /&gt;
| pKb = &lt;br /&gt;
  }}&lt;br /&gt;
|Section5={{Chembox Pharmacology&lt;br /&gt;
| AdminRoutes = &lt;br /&gt;
| Bioavail = &lt;br /&gt;
| Metabolism = &lt;br /&gt;
| HalfLife = &lt;br /&gt;
| ProteinBound =&lt;br /&gt;
| Excretion = &lt;br /&gt;
| Legal_status = &lt;br /&gt;
| Legal_US = &lt;br /&gt;
| Legal_UK = &lt;br /&gt;
| Legal_AU = &lt;br /&gt;
| Legal_CA = &lt;br /&gt;
| Pregnancy_category = &lt;br /&gt;
| Pregnancy_AU = &lt;br /&gt;
| Pregnancy_US = &lt;br /&gt;
  }}&lt;br /&gt;
|Section7={{Chembox Hazards&lt;br /&gt;
| ExternalSDS = &lt;br /&gt;
| MainHazards = &lt;br /&gt;
| NFPA-H = &lt;br /&gt;
| NFPA-F = &lt;br /&gt;
| NFPA-R = &lt;br /&gt;
| NFPA-S = &lt;br /&gt;
| FlashPt = &lt;br /&gt;
| AutoignitionPt = &lt;br /&gt;
| ExploLimits = &lt;br /&gt;
| LD50 =&lt;br /&gt;
| PEL = &lt;br /&gt;
  }}&lt;br /&gt;
|Section8={{Chembox Related&lt;br /&gt;
| OtherAnions = &lt;br /&gt;
| OtherCations = &lt;br /&gt;
| OtherFunction = &lt;br /&gt;
| OtherFunction_label = &lt;br /&gt;
| OtherCompounds = &lt;br /&gt;
  }}&lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;AR-R17779&amp;#039;&amp;#039;&amp;#039;，分子式[[C9H14N2O2|C&amp;lt;sub&amp;gt;9&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;14&amp;lt;/sub&amp;gt;N&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;]]，是[[CHRNA7|α7]][[菸鹼型乙醯膽鹼受體]]的完全[[激动剂]]&amp;lt;ref&amp;gt;{{Cite journal &lt;br /&gt;
| pmid = 11063601 &lt;br /&gt;
| year = 2000 &lt;br /&gt;
| last1 = Mullen | first1 = G. &lt;br /&gt;
| last2 = Napier | first2 = A.&lt;br /&gt;
| last3 = Balestra | first3 = M. &lt;br /&gt;
| last4 = Decory | first4 = T. &lt;br /&gt;
| last5 = Hale | first5 = G. &lt;br /&gt;
| last6 = Macor | first6 = J. &lt;br /&gt;
| last7 = Mack | first7 = R. &lt;br /&gt;
| last8 = Loch | first8 = J. &lt;br /&gt;
| last9 = Wu | first9 = E. &lt;br /&gt;
| last10 = Kover | first10 = A. &lt;br /&gt;
| last11 = Verhoest | first11 = P. &lt;br /&gt;
| last12 = Sampognaro | first12 = A. &lt;br /&gt;
| last13 = Phillips | first13 = E. &lt;br /&gt;
| last14 = Zhu | first14 = Y. &lt;br /&gt;
| last15 = Murray | first15 = R. &lt;br /&gt;
| last16 = Griffith | first16 = R. &lt;br /&gt;
| last17 = Blosser | first17 = J. &lt;br /&gt;
| last18 = Gurley | first18 = D. &lt;br /&gt;
| last19 = Machulskis | first19 = A. &lt;br /&gt;
| last20 = Zongrone | first20 = J. &lt;br /&gt;
| last21 = Rosen | first21 = A. &lt;br /&gt;
| last22 = Gordon | first22 = J. &lt;br /&gt;
| title = (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor &lt;br /&gt;
| volume = 43 &lt;br /&gt;
| issue = 22 &lt;br /&gt;
| pages = 4045–4050 &lt;br /&gt;
| journal = [[Journal of Medicinal Chemistry]]&lt;br /&gt;
| doi = 10.1021/jm000249r&lt;br /&gt;
}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal&lt;br /&gt;
| last1 = Macor | first1 = J.&lt;br /&gt;
| last2 = Mullen | first2 = G.&lt;br /&gt;
| last3 = Verhoest | first3 = P.&lt;br /&gt;
| last4 = Sampognaro | first4 = A.&lt;br /&gt;
| last5 = Shepardson | first5 = B.&lt;br /&gt;
| last6 = Mack | first6 = R.&lt;br /&gt;
| title = A chiral synthesis of (−)-spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one]: A conformationally restricted analogue of acetylcholine that is a potent and selective α7 nicotinic receptor agonist&lt;br /&gt;
| journal = The Journal of Organic Chemistry&lt;br /&gt;
| volume = 69&lt;br /&gt;
| issue = 19&lt;br /&gt;
| pages = 6493–6495&lt;br /&gt;
| year = 2004&lt;br /&gt;
| pmid = 15357617 &lt;br /&gt;
| doi = 10.1021/jo049404q &lt;br /&gt;
}}&amp;lt;/ref&amp;gt;。&lt;br /&gt;
&lt;br /&gt;
== 参考文献 ==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
== 外部链接 ==&lt;br /&gt;
{{chem-stub}}&lt;br /&gt;
&lt;br /&gt;
[[Category:兴奋剂]]&lt;br /&gt;
[[Category:促智药]]&lt;br /&gt;
[[Category:螺环化合物]]&lt;br /&gt;
[[Category:烟碱激动剂]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Nucleus hydro elemon</name></author>
	</entry>
</feed>